Chemoinformaics analysis of 1,6-Dihydroxy-3,5,7-trimethoxyxanthen-9-one
| Molecular Weight | 318.281 | nRot | 3 |
| Heavy Atom Molecular Weight | 304.169 | nRig | 17 |
| Exact Molecular Weight | 318.074 | nRing | 3 |
| Solubility: LogS | -3.838 | nHRing | 1 |
| Solubility: LogP | 2.644 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 41.6691 |
| nHD | 2 | BPOL | 21.8569 |
| QED | 0.715 |
| Synth | 2.45 |
| Natural Product Likeliness | 1.416 |
| NR-PPAR-gamma | 0.96 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.743 |
| Pgp-sub | 0.003 |
| HIA | 0.042 |
| CACO-2 | -4.968 |
| MDCK | 0.0000265 |
| BBB | 0.011 |
| PPB | 0.813868 |
| VDSS | 0.945 |
| FU | 0.237395 |
| CYP1A2-inh | 0.887 |
| CYP1A2-sub | 0.973 |
| CYP2c19-inh | 0.148 |
| CYP2c19-sub | 0.516 |
| CYP2c9-inh | 0.519 |
| CYP2c9-sub | 0.877 |
| CYP2d6-inh | 0.303 |
| CYP2d6-sub | 0.71 |
| CYP3a4-inh | 0.356 |
| CYP3a4-sub | 0.203 |
| CL | 5.026 |
| T12 | 0.768 |
| hERG | 0.019 |
| Ames | 0.588 |
| ROA | 0.381 |
| SkinSen | 0.786 |
| Carcinogencity | 0.028 |
| EI | 0.73 |
| Respiratory | 0.421 |
| NR-Aromatase | 0.88 |
| Antiviral | Yes |
| Prediction | 0.828355 |